Skip to main content

Solventum Corp

SOLV
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001964738

No open-market purchases or sales by Solventum Corp insiders were filed in the last 90 days; 890 institutions reported holding it in 13F filings for Q2 2026, worth $9.84B in total; Trian Fund Management is the only superinvestor holding it.

Key figures

Market capClose on Nov 10, 2026
$15.3B
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +8 vs. previous quarter
890
13F valueReported value at the end of Q2 2026
$9.84B
Superinvestors holdingAt the end of Q2 2026
1

Price chart

From SEC filings, in USD.

Revenue, FY2025
$8.32B
+0.9% year over year
Net income, FY2025
$1.56B
+224.8% year over year
Free cash flow, FY2025
-$10.0M
−101.2% year over year
Revenue, Q3 FY2026
$1.95B
−7.0% year over year

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
5.05M
Shares sold short
Change
+95.7K
+1.9% vs. previous
Days to cover
4.60
At average daily volume

Superinvestors holding SOLV, Q2 2026

Go to the superinvestors tab

1 superinvestor reports holding Solventum Corp on Form 13F. Percentages are the stock's share of each portfolio.

Trian Fund Management

Nelson Peltz

15.0%

Solventum Corp's share of the portfolio

Shares
8,236,753
Value
$635.5M

Latest insider trades

See all insider trades

Open-market purchases and sales by Solventum Corp insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 11, 2026 (view filing)Mar 101 dayWendell Amy McBrideDirectorPPurchase+1.48K$68.03+$100.3K+41.4%5.04K after
Aug 18, 2025 (view filing)Aug 153 days3M Co10% OwnerSSale−8.80M$73.45−$646.4M−25.6%25.6M after

Top 10 13F holders, Q2 2026

See all 890 holders

The largest institutional positions in Solventum Corp at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding SOLV in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Independent Franchise Partners LLP16,170,038$1.25B8.18%+436,543+2.8%Added
BlackRock, Inc.9,761,863$753.1M0.01%−717,109−6.8%Reduced
Vanguard Capital Management LLC9,624,829$742.6M0.02%+22,880+0.2%Added
Trian Fund Management, L.P.SuperinvestorTrian Fund Management8,236,753$635.5M15.02%00.0%Unchanged
Vanguard Portfolio Management LLC6,328,641$488.3M0.02%−61,723−1.0%Reduced
Davis Selected Advisers6,307,729$486.7M2.09%−22,596−0.4%Reduced
State Street Corp5,639,230$435.1M0.01%−768,250−12.0%Reduced
Geode Capital Management, LLC4,910,624$378.3M0.02%+158,364+3.3%Added
Boston Partners4,037,963$311.5M0.28%+123,872+3.2%Added
Invesco Ltd.3,309,915$255.4M0.02%−479,968−12.7%Reduced

Holders of 5% or more of SOLV

See all 3 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Solventum Corp.

Largest holders of SOLV from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
3M Co13G/A14.80%25.6M shares−5.10 ppfrom 19.90%Nov 14, 20242 filingsAug 18, 2025SEC
Independent Franchise Partners LLP13G/A8.85%15.4M shares+1.41 ppfrom 7.44%Aug 13, 20253 filingsJan 27, 2026SEC
Vanguard Capital Management LLC13G6.27%10.9M sharesNewApr 30, 20261 filingApr 30, 2026SEC

6 members of Congress reported 6 trades in Solventum Corp since 2020. Newest filings:

  1. Tommy Tuberville

    Senate · AL · Aug 5, 2026

    Sell (full)$1K-$15K

  2. Alan Armstrong

    Senate · OK · Jul 21, 2026

    Buy$1K-$15K

  3. J. French Hill

    House · AR · Jan 23, 2026

    Sell$15K-$50K

  4. Ron Wyden

    Senate · OR · Feb 21, 2025

    Sell (full)$1K-$15K

  5. Julie Johnson

    House · TX · Feb 12, 2025

    Sell$1K-$15K